Approach and management of checkpoint inhibitor-related immune hepatitis

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Immune checkpoint inhibitors have promising clinical activity across multiple gastrointestinal cancers and immune-mediated hepatotoxicity is particularly relevant for this group of patients. In this article we will review the recognition, workup and management of suspected checkpoint inhibitor related immunehepatitis.

Original languageEnglish (US)
Pages (from-to)220-224
Number of pages5
JournalJournal of Gastrointestinal Oncology
Volume9
Issue number1
DOIs
StatePublished - Feb 1 2018

Fingerprint

Gastrointestinal Neoplasms
Hepatitis

Keywords

  • Gastrointestinal cancers
  • Immune checkpoint inhibitors
  • Immune-mediated toxicity
  • Immunotherapy

ASJC Scopus subject areas

  • Oncology
  • Gastroenterology

Cite this

Approach and management of checkpoint inhibitor-related immune hepatitis. / Sanjeevaiah, Aravind; Kerr, Thomas; Beg, Muhammad Shaalan.

In: Journal of Gastrointestinal Oncology, Vol. 9, No. 1, 01.02.2018, p. 220-224.

Research output: Contribution to journalArticle

@article{d76f5f06a473485ab21073c44c3e16a5,
title = "Approach and management of checkpoint inhibitor-related immune hepatitis",
abstract = "Immune checkpoint inhibitors have promising clinical activity across multiple gastrointestinal cancers and immune-mediated hepatotoxicity is particularly relevant for this group of patients. In this article we will review the recognition, workup and management of suspected checkpoint inhibitor related immunehepatitis.",
keywords = "Gastrointestinal cancers, Immune checkpoint inhibitors, Immune-mediated toxicity, Immunotherapy",
author = "Aravind Sanjeevaiah and Thomas Kerr and Beg, {Muhammad Shaalan}",
year = "2018",
month = "2",
day = "1",
doi = "10.21037/jgo.2017.08.14",
language = "English (US)",
volume = "9",
pages = "220--224",
journal = "Journal of Gastrointestinal Oncology",
issn = "2078-6891",
publisher = "Pioneer Bioscience Publishing Company (PBPC)",
number = "1",

}

TY - JOUR

T1 - Approach and management of checkpoint inhibitor-related immune hepatitis

AU - Sanjeevaiah, Aravind

AU - Kerr, Thomas

AU - Beg, Muhammad Shaalan

PY - 2018/2/1

Y1 - 2018/2/1

N2 - Immune checkpoint inhibitors have promising clinical activity across multiple gastrointestinal cancers and immune-mediated hepatotoxicity is particularly relevant for this group of patients. In this article we will review the recognition, workup and management of suspected checkpoint inhibitor related immunehepatitis.

AB - Immune checkpoint inhibitors have promising clinical activity across multiple gastrointestinal cancers and immune-mediated hepatotoxicity is particularly relevant for this group of patients. In this article we will review the recognition, workup and management of suspected checkpoint inhibitor related immunehepatitis.

KW - Gastrointestinal cancers

KW - Immune checkpoint inhibitors

KW - Immune-mediated toxicity

KW - Immunotherapy

UR - http://www.scopus.com/inward/record.url?scp=85041701184&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85041701184&partnerID=8YFLogxK

U2 - 10.21037/jgo.2017.08.14

DO - 10.21037/jgo.2017.08.14

M3 - Article

C2 - 29564187

AN - SCOPUS:85041701184

VL - 9

SP - 220

EP - 224

JO - Journal of Gastrointestinal Oncology

JF - Journal of Gastrointestinal Oncology

SN - 2078-6891

IS - 1

ER -